General Public
Patients with Dengue, Zika, and Tropical Diseases
International Partners (Solomon Islands, India)
Established in 2008, the Tropical Medicine Center at KMUH manages the sole BSL-3 laboratory within the KMU healthcare system. Guided by the spirit of compassion and humanity, the center actively develops education, research, and clinical services. Our core services focus on the prevention and control of dengue fever and emerging diseases. Internationally, we have long been deeply engaged in medical and public health services, including intestinal parasite and dengue control in the Solomon Islands, as well as missions in Tibetan refugee settlements in India. Notably, our extensive experience in dengue management has not only benefited domestic patients but has also been successfully exported to the Solomon Islands. In the Tibetan refugee settlements, our work extends beyond charitable medical clinics to implementing vital public health interventions, such as water quality improvement, HIV/AIDS prevention, vision care, and health education. Looking to the future, global warming will undoubtedly expand and intensify the threat of tropical infectious diseases. By sharing the center’s operational model developed over the past decade, we aim to establish a benchmark for the internationalization of tropical medicine centers in Taiwan.
Dual-Certified Lab: Taiwan's first laboratory with CDC/TAF dual certification for three major dengue testing items.
The Only Exhibition Hall: The nation’s sole dedicated educational exhibition space for dengue fever.
Specialized Outpatient Clinic: Southern Taiwan's exclusive specialized clinic for Dengue, Zika, and tropical diseases.
BSL-3 Lab: The sole BSL-3 laboratory capable of SARS-CoV-2 cultivation within the Kaohsiung-Pingtung region.
Academic Leader: Ranked number one among all Taiwanese hospitals for the highest volume of published dengue research papers.
3-in-1 Clinical Model: A pioneering, highly integrated dengue care framework combining clinical observation, rapid diagnosis, and laboratory testing.
Outpatient Service Volume (2008–Present):93,167 patient visits across the Division of Infectious Diseases, Specialized Tropical Medicine Clinic, and Mpox Clinic.
Centralized Diagnostic Testing:11,393 clinical specimens processed.
Academic Lectures & Seminars (2006–Present):3,918 participants across 30 sessions. SARS-CoV-2 Cultivation & Sequencing: Successfully cultured and uploaded 126 viral sequences to GISAID.
High-Impact Scientific Publications: Out of 95 SCI papers published to date, 64.8% (nearly two-thirds) are featured in top-tier Q1 and Q2 international journals.
Project completion rate: 100%。
Report modification rate: 0%。
COVID culture success rate: 28%。
64.8% papers in Q1/Q2 journals。
44% papers in top Q1 journals。
Annual CDC testing passed 。
TAF ISO15189 certified 。
Monthly review triggers RCA 。
Report delay rate <3% 。
Report modification <3% 。
Specimen rejection rate: 0% 。
QC anomaly rate below 3% 。
100% test pass rate (8 yrs)。
100% staff satisfaction rate 。
90% trial subjects very satisfied 。
Seminar satisfaction >80% (30 events)。
Long-Term Mission in the Solomon Islands (2009–2017): Deeply engaged in the Solomon Islands, successfully securing strategic project funding from the Ministry of Foreign Affairs (MOFA) and the Ministry of Health and Welfare (MOHW).
Establishing Critical Laboratory Infrastructure: Planned and built the very first Biosafety Level 2 (BSL-2) dengue virus identification laboratory in the Solomon Islands.
Global Pandemic Response & WHO Collaboration: Collaborated directly with the World Health Organization (WHO) in 2013 to provide professional anti-epidemic guidance during the major dengue outbreak in the Solomon Islands.
Prestigious International Medical Recognition: Honored with the International Medical Exemplary Award, receiving the Group Award in the 1st edition and the Individual Award in the 2nd edition.
International Medical Aid & Infrastructure (Since 2009): Initiated humanitarian medical missions in Tibetan refugee settlements, establishing the locality's first simplified operating room and clean water system.
Global Academic Exchange & Official Visits: Hosted international visitors and official delegations from countries including Thailand, the Philippines, India, Singapore, and Honduras.
Drafted CDC dengue SOP manual National Guideline Development & Standardization: Assisted the Taiwan Centers for Disease Control (CDC) in drafting the Dengue Clinical Manual and establishing standardized clinical diagnosis and treatment SOPs.
Clinical Mentorship & Regional Response Empowerment: Guided the Dengue Response Hospital in Tainan, providing frontline physicians with critical clinical management techniques and protocols.
Transnational Laboratory Capacity Building: Trained laboratory technicians from the Solomon Islands in Taiwan and traveled onsite to assist in establishing advanced diagnostic and testing methods.
Substantial Public Health Impact & Outbreak Prevention: Successfully prevented major dengue outbreaks in the Solomon Islands during 2014–2015 and 2017–2019, maintaining only sporadic cases.
Prestigious Global Recognition by Governments and WHO: The KMUH team's extensive clinical and preventive efforts in the Solomon Islands received high praise and official recognition from both the local government and the WHO.
Extensive Media Coverage & Global Brand Impact: Attracted focused coverage from major domestic and international media outlets, including TV Asahi (Japan), the three major newspapers of the Solomon Islands, Da Ai TV, PTS, Business Weekly, and leading Taiwanese press.
